Mad Money

Lightning Round: It's still too early to buy this

Share

It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Array Biopharma: "The last program that they had was not up to snuff, which is why the stock came down. But they have others. I will sanction it only as a pure spec and not adjust the spec."

Groupon: "We are not fans of Groupon. It is too early to buy Groupon. There are still a lot of things that are not working there."

Motorola Solutions: "I would take it. Let's move on."

Bed Bath & Beyond: "I have to tell you, I think there are better retailers out there to buy. In particular I would say TJX is better. They just put up a good quarter."

SunEdison: "We did a large piece on why we recommended it, and we should have pulled it, and we didn't. I have to tell you, I don't think it's a great stock here. A lot of things have to go right. I would sell it into strength."

EOG Resources: "My charitable trust owns it, we have a long-term time horizon and think it's terrific."

Read more from Mad Money with Jim Cramer

Cramer Remix: Surprise! This group has a pulse
Cramer: China could cause biotech stocks to plunge
Cramer: This rally is all about the Fed—not stocks

Williams Partners: "I think it's terrific. I know that there are cross-currents here and arbitrage, but I do think it's great. I think that the yield is for real."

Natus Medical: "We like that device company. I took a hard look at it and it's a good situation."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com